(BKYI) BIO-Key International - Ratings and Ratios

BIO-key International, Inc. is a leading provider of biometric technology and identity access management solutions, catering to commercial, government, and education sectors globally. The companys flagship products, BIO-key PortalGuard and PortalGuard IDaaS, offer a cloud-based identity platform that enables seamless integration with various cloud and on-premises applications, ensuring secure workforce and student population management. Additionally, BIO-keys solutions facilitate collaborative partner networks and provide robust security features, including multi-factor authentication and access control.

The companys product portfolio includes a range of finger scanners, such as SideSwipe, PIV Pro, EcoID II, and SidePass, designed for enterprise and consumer markets, as well as fingerprint readers. BIO-keys identity and access management solutions are designed to secure user identities and prevent unauthorized access. With a history dating back to 1993, the company has established itself as a pioneer in the biometric technology space, with a strong presence in the United States and international markets.

From a technical analysis perspective, BKYIs stock price has been trending downwards, with the short-term and long-term moving averages (SMA20 and SMA200) indicating a bearish sentiment. The Average True Range (ATR) suggests a relatively high volatility, with a 10.18% fluctuation in the stock price. Considering the fundamental data, the companys market capitalization stands at $4.77M USD, with a negative Return on Equity (RoE) of -174.52, indicating significant losses.

Based on the technical and fundamental data, a forecast for BKYIs stock price suggests a potential continuation of the downtrend, with a possible target price range between $0.59 and $0.70 in the short term. However, if the company can demonstrate significant improvements in its financial performance and product offerings, a reversal of the trend is possible, with a potential target price range between $1.50 and $2.00 in the long term. Nevertheless, the high volatility and negative RoE indicate a high-risk investment, and investors should exercise caution when considering BKYI as a potential investment opportunity.